Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.62% |
| 3 | Healthcare | 7.1% |
| 4 | Industrials | 5.08% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
CVRx
CVRX
$65.3M
| $2.87M | ﹤0.01% |
477,745
-26,927
| -5% | -$155K |
|
3302
TripAdvisor
TRIP
$1.28B
| $2.87M | ﹤0.01% |
161,320
+107,533
| +200% | +$2.55M |
|
|
PGSS
3303
DELISTED
Pegasus Digital Mobility Acquisition Corp.
PGSS
| $2.87M | ﹤0.01% |
288,798
+139,841
| +94% | +$1.39M |
|
3304
PUT
Arthur J. Gallagher & Co
AJG
$64.7B
| $2.87M | ﹤0.01% |
+17,600
| New | +$2.92M |
|
3305
DigitalBridge
DBRG
$2.94B
| $2.87M | ﹤0.01% |
147,000
+67,441
| +85% | +$1.65M |
|
|
RNER
3306
DELISTED
Mount Rainier Acquisition Corp. Common Stock
RNER
| $2.86M | ﹤0.01% |
284,727
-82,713
| -23% | -$828K |
|
3307
Nauticus Robotics
KITT
$8.21M
| $2.86M | ﹤0.01% |
110
-20
| -15% | -$521K |
|
3308
CALL
Fiverr
FVRR
$328M
| $2.86M | ﹤0.01% |
83,100
+23,200
| +39% | +$1.1M |
|
3309
Amphastar Pharmaceuticals
AMPH
$860M
| $2.85M | ﹤0.01% |
82,041
-91,280
| -53% | -$3.26M |
|
|
ITCI
3310
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.85M | ﹤0.01% |
+50,000
| New | +$2.83M |
|
|
FOLD
3311
DELISTED
Amicus Therapeutics
FOLD
| $2.85M | ﹤0.01% |
265,213
+171,980
| +184% | +$1.42M |
|
3312
Green Brick Partners
GRBK
$3.06B
| $2.85M | ﹤0.01% |
145,436
-323,034
| -69% | -$6.78M |
|
|
TMPM
3313
DELISTED
Turmeric Acquisition Corp. Class A Ordinary Shares
TMPM
| $2.84M | ﹤0.01% |
286,235
-10,236
| -3% | -$101K |
|
|
JBTM
3314
JBT Marel
JBTM
$6.37B
| $2.84M | ﹤0.01% |
25,722
+20,255
| +370% | +$2.33M |
|
3315
Carrier Global
CARR
$52.1B
| $2.84M | ﹤0.01% |
79,568
-226,980
| -74% | -$8.91M |
|
3316
Fidelity D&D Bancorp
FDBC
$319M
| $2.83M | ﹤0.01% |
69,650
+63,329
| +1,002% | +$2.47M |
|
|
GAP
3317
The Gap Inc
GAP
$7.63B
| $2.83M | ﹤0.01% |
343,987
+54,277
| +19% | +$628K |
|
3318
Genius Sports
GENI
$2.16B
| $2.83M | ﹤0.01% |
1,257,517
+668,829
| +114% | +$2.26M |
|
|
MOMO
3319
Hello Group
MOMO
$873M
| $2.83M | ﹤0.01% |
560,028
-46,401
| -8% | -$243K |
|
|
RAM
3320
DELISTED
Aries I Acquisition Corporation Class A Ordinary Share
RAM
| $2.82M | ﹤0.01% |
279,608
+39,142
| +16% | +$395K |
|
3321
Coherus Oncology
CHRS
$185M
| $2.82M | ﹤0.01% |
389,305
+187,245
| +93% | +$1.63M |
|
3322
iShares Russell Mid-Cap ETF
IWR
$57.7B
| $2.81M | ﹤0.01% |
43,508
+18,149
| +72% | +$1.29M |
|
|
BNY
3323
PUT
Bank of New York Mellon
BNY
$109B
| $2.81M | ﹤0.01% |
+67,400
| New | +$3M |
|
3324
Globus Medical
GMED
$11.5B
| $2.81M | ﹤0.01% |
50,031
-44,807
| -47% | -$2.95M |
|
3325
Arhaus
ARHS
$1.41B
| $2.8M | ﹤0.01% |
622,610
+565,276
| +986% | +$3.7M |
|
Similar funds
Millennium Management's Q2 2022 Portfolio in Review
As of Q2 2022, Millennium Management held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Millennium Management's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Millennium Management added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Millennium Management's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Millennium Management fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Millennium Management's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Millennium Management opened 1,144 new positions and closed 1,065 in Q2 2022.
- Millennium Management's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.